Literature DB >> 15340696

[Relevance of sleep for patients with lung diseases].

H F Becker1.   

Abstract

Sleep is characterized by a profound change of load and capacity of the respiratory system. Load increases due to a rise in upper and lower airway resistance. Capacity decreases due to reduced chemosensitivity, a decrease in muscle activity and minute ventilation. Whereas these changes do not lead to relevant blood gas changes and do not disturb sleep in healthy subjects, patients with respiratory diseases frequently show the first symptoms of their disease during sleep. Pulmonary diseases in which sleep plays an important role are asthma, COPD, hypercapnic respiratory failure, sleep disordered breathing, the overlap-syndrome and cystic fibrosis. Medical history should include sleep and complaints during the night. In asthmatics peak-flow measurements during the night may provide valuable information. In all other disorders mentioned, nocturnal ambulatory recording of respiration and arterial oxygen saturation often allow the detection of relevant disorders of breathing during sleep. If ambulatory monitoring reveals relevant pathology, then further evaluation and treatment in the sleep laboratory are warranted.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15340696     DOI: 10.1007/s00108-004-1260-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  57 in total

1.  Nocturnal asthma is associated with reduced glucocorticoid receptor binding affinity and decreased steroid responsiveness at night.

Authors:  M Kraft; E Vianna; R J Martin; D Y Leung
Journal:  J Allergy Clin Immunol       Date:  1999-01       Impact factor: 10.793

2.  Do asthmatics suffer bronchoconstriction during rapid eye movement sleep?

Authors:  C M Shapiro; J R Catterall; I Montgomery; G M Raab; N J Douglas
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-03

3.  Low-flow oxygen and bilevel ventilatory support: effects on ventilation during sleep in cystic fibrosis.

Authors:  M A Milross; A J Piper; M Norman; H F Becker; G N Willson; R R Grunstein; C E Sullivan; P T Bye
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

4.  Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations.

Authors:  S Javaheri; T J Parker; J D Liming; W S Corbett; H Nishiyama; L Wexler; G A Roselle
Journal:  Circulation       Date:  1998-06-02       Impact factor: 29.690

5.  Breathing during sleep in patients with nocturnal desaturation.

Authors:  H F Becker; A J Piper; W E Flynn; S G McNamara; R R Grunstein; J H Peter; C E Sullivan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

6.  Parasympathetic nervous system in nocturnal asthma.

Authors:  J F Morrison; S B Pearson; H G Dean
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-21

7.  Domiciliary nocturnal nasal intermittent positive pressure ventilation in COPD: mechanisms underlying changes in arterial blood gas tensions.

Authors:  M W Elliott; D A Mulvey; J Moxham; M Green; M A Branthwaite
Journal:  Eur Respir J       Date:  1991-10       Impact factor: 16.671

8.  [Sleep disorders and sleep-related breathing disorders].

Authors:  H F Becker; G Mayer; T Penzel
Journal:  Internist (Berl)       Date:  2004-01       Impact factor: 0.743

9.  Nasal intermittent positive pressure ventilation. Analysis of its withdrawal.

Authors:  J F Masa Jiménez; J Sánchez de Cos Escuin; C Disdier Vicente; M Hernández Valle; F Fuentes Otero
Journal:  Chest       Date:  1995-02       Impact factor: 9.410

10.  Ventilatory and arousal responses to hypoxia in sleeping humans.

Authors:  M Berthon-Jones; C E Sullivan
Journal:  Am Rev Respir Dis       Date:  1982-06
View more
  1 in total

1.  Associations of Alcohol Consumption and Chronic Diseases With Sleep Apnea Among US Adults.

Authors:  Yue Pan; Weize Wang; Ke-Sheng Wang
Journal:  Int J High Risk Behav Addict       Date:  2014-05-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.